Leland Gershell is a seasoned finance and biopharma professional with a robust background in leadership roles across several companies. Currently serving as Managing Director and Senior Biopharma Analyst at Oppenheimer & Co. Inc., Leland has previously held key positions as Chief Financial Officer at both Capricor Therapeutics, Inc. and Tonix Pharmaceuticals. Additionally, Leland has experience as Managing Director at Madison Williams and Company and as a Senior Analyst at Apothecary Capital LLC. Leland's academic credentials include an MD in Medicine and a PhD in Organic Chemistry, both from Columbia University, with studies extending from 1994 to 2002.
February, 2018 - present